Affluent Medical Past Earnings Performance
Past criteria checks 0/6
Affluent Medical's earnings have been declining at an average annual rate of -1.5%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been declining at an average rate of 2% per year.
Key information
-1.5%
Earnings growth rate
21.8%
EPS growth rate
| Medical Equipment Industry Growth | 21.6% |
| Revenue growth rate | -2.0% |
| Return on equity | -54.1% |
| Net Margin | -1,315.9% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Affluent Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -17 | 13 | 0 |
| 31 Mar 24 | 1 | -16 | 13 | 0 |
| 31 Dec 23 | 1 | -16 | 12 | 0 |
| 30 Sep 23 | 1 | -15 | 11 | 0 |
| 30 Jun 23 | 1 | -15 | 11 | 0 |
| 31 Mar 23 | 1 | -15 | 11 | 0 |
| 31 Dec 22 | 1 | -15 | 11 | 0 |
| 30 Sep 22 | 1 | -15 | 10 | 0 |
| 30 Jun 22 | 2 | -15 | 9 | 0 |
| 31 Mar 22 | 2 | -15 | 10 | 0 |
| 31 Dec 21 | 1 | -15 | 10 | 0 |
| 30 Sep 21 | 1 | -15 | 10 | 0 |
| 30 Jun 21 | 1 | -15 | 10 | 0 |
| 31 Mar 21 | 1 | -15 | 9 | 0 |
| 31 Dec 20 | 1 | -14 | 8 | 0 |
| 31 Dec 19 | 1 | -17 | 7 | 0 |
| 31 Dec 17 | 1 | -9 | 4 | 0 |
| 31 Dec 16 | 1 | -6 | 3 | 0 |
Quality Earnings: AFME is currently unprofitable.
Growing Profit Margin: AFME is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AFME is unprofitable, and losses have increased over the past 5 years at a rate of 1.5% per year.
Accelerating Growth: Unable to compare AFME's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AFME is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Return on Equity
High ROE: AFME has a negative Return on Equity (-54.06%), as it is currently unprofitable.